Note Agreements in the Biotechnology Industry

1,894 Contracts & Agreements

Browse by Company

AbbVie Inc. (8 contracts)
ABEONA THERAPEUTICS INC. (5)
ACADIA PHARMACEUTICALS INC (1)
ACCELERON PHARMA INC (1)
Acorda Therapeutics (5)
Adamas Pharmaceuticals Inc (2)
Adhera Therapeutics, Inc. (30)
ADiTx Therapeutics, Inc. (41)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (30)
AGENUS INC (11)
AgeX Therapeutics, Inc. (15)
Akebia Therapeutics, Inc. (5)
Alexion Pharmaceuticals (2)
Allarity Therapeutics, Inc. (10)
Alliqua BioMedical, Inc. (19)
Alpha Healthcare Acquisition Corp. (1)
Altimmune, Inc. (5)
Alzamend Neuro, Inc. (2)
AMARILLO BIOSCIENCES INC (15)
AMARIN CORP PLC (1)
Amgen Inc. (17)
AMICUS THERAPEUTICS, INC. (10)
AmpliPhi Biosciences Corp (1)
Amplitude Healthcare Acquisition Corp (1)
ANAVEX LIFE SCIENCES CORP. (7)
Aptevo Therapeutics Inc. (1)
AquaBounty Technologies, Inc. (2)
Aridis Pharmaceuticals, Inc. (4)
ARROWHEAD PHARMACEUTICALS, INC. (1)
Artiva Biotherapeutics, Inc. (1)
ARYA Sciences Acquisition Corp II (1)
ASSEMBLY BIOSCIENCES, INC. (4)
ATHERSYS, INC (1)
aTYR PHARMA INC (1)
Avid Bioservices, Inc. (3)
Axcella Health Inc. (1)
AZIYO BIOLOGICS, INC. (3)
AzurRx BioPharma, Inc. (4)
BeiGene, Ltd. (1)
BELLICUM PHARMACEUTICALS, INC (1)
Big Cypress Acquisition Corp. (1)
bioAffinity Technologies, Inc. (8)
BioAtla, Inc. (1)
BioCardia, Inc. (6)
BIOCEPT INC (10)
Biogen Inc. (3)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BioLife4D Corp (18)
BIOMARIN PHARMACEUTICAL INC (6)
BioRestorative Therapies, Inc. (23)
Biostage, Inc. (2)
BIOTIME INC (4)
BioXcel Therapeutics, Inc. (1)
BIOXYTRAN, INC (16)
Bone Biologics Corp (24)
BullFrog AI Holdings, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (3)
Calyxt, Inc. (2)
CANCER GENETICS, INC (12)
CAPRICOR THERAPEUTICS, INC. (3)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (7)
Capstone Therapeutics Corp. (6)
CareDx, Inc. (1)
Caribou Biosciences, Inc. (1)
CASI Pharmaceuticals, Inc. (8)
Castle Creek Biosciences, Inc. (1)
CATALYST BIOSCIENCES, INC. (4)
CATALYST PHARMACEUTICALS, INC. (1)
CEL SCI CORP (1)
Celcuity Inc. (1)
Cell Source, Inc. (29)
Celldex Therapeutics, Inc. (2)
Cellectar Biosciences, Inc. (2)
Celsion CORP (1)
Centessa Pharmaceuticals Ltd (3)
CEREBAIN BIOTECH CORP. (18)
Chanticleer Holdings, Inc. (5)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (2)
Chelsea Worldwide Inc. (3)
CHIMERIX INC (1)
CLEVELAND BIOLABS INC (4)
CM Life Sciences III Inc. (1)
CohBar, Inc. (1)
Coherus BioSciences, Inc. (3)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (3)
Consonance-HFW Acquisition Corp. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (40)
CTD HOLDINGS INC (15)
CTI BIOPHARMA CORP (2)
Curative Biotechnology Inc (25)
CURIS INC (3)
Cyclacel Pharmaceuticals, Inc. (1)
CytoDyn Inc. (21)
CYTORI THERAPEUTICS, INC. (4)
DelMar Pharmaceuticals, Inc. (1)
Diffusion Pharmaceuticals Inc. (6)
Digital Development Partners, Inc. (14)
DYADIC INTERNATIONAL INC (5)
Dynamics Special Purpose Corp. (4)
Eidos Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (4)
ENDONOVO THERAPEUTICS, INC. (9)
Enochian Biosciences Inc (9)
Entasis Therapeutics Holdings Inc. (1)
Environmental Impact Acquisition Corp (3)
Esperion Therapeutics, Inc. (1)
Exelixis (6)
FATE THERAPEUTICS INC (4)
FENNEC PHARMACEUTICALS INC. (1)
Fibrocell Science, Inc. (3)
FLUOROPHARMA MEDICAL, INC. (15)
Fortress Biotech, Inc. (6)
FS Development Corp. (1)
FS Development Corp. II (2)
GALECTIN THERAPEUTICS INC (5)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (9)
GENELUX CORP (3)
GENEREX BIOTECHNOLOGY CORP (10)
Genprex, Inc. (3)
GeoVax Labs, Inc. (5)
GERON CORP (4)
Gilead Sciences (8)
Greater Cannabis Company, Inc. (15)
GT Biopharma, Inc. (27)
GX Acquisition Corp. (3)
HALOZYME THERAPEUTICS INC (2)
HARBOR DIVERSIFIED, INC. (2)
HCW Biologics Inc. (5)
Health Sciences Acquisitions Corp (1)
HEAT BIOLOGICS, INC. (8)
HedgePath Pharmaceuticals, Inc. (6)
HEMISPHERX BIOPHARMA INC (8)
HERON THERAPEUTICS, INC. (3)
HilleVax, Inc. (1)
Hillstream BioPharma Inc. (2)
HISTOGENICS CORP (5)
Homology Medicines, Inc. (2)
HUMANIGEN, INC (9)
iBio, Inc. (3)
IDERA PHARMACEUTICALS, INC. (2)
Immix Biopharma, Inc. (1)
IMMUCELL CORP (6)
IMMUNE PHARMACEUTICALS INC (13)
Immune Therapeutics, Inc. (30)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (1)
IMPEL NEUROPHARMA INC (1)
Incyte (2)
INFINITY PHARMACEUTICALS, INC. (1)
Inhibikase Therapeutics, Inc. (6)
Inhibrx, Inc. (3)
Innovation Pharmaceuticals Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (1)
INTERCEPT PHARMACEUTICALS, INC. (1)
International Stem Cell CORP (33)
INTREXON CORP (2)
Intrinsic Medicine, Inc. (1)
Invitae Corp (4)
IONIS PHARMACEUTICALS INC (2)
IOVANCE BIOTHERAPEUTICS, INC. (10)
IRONWOOD PHARMACEUTICALS INC (5)
Isoray, Inc. (2)
KalVista Pharmaceuticals, Inc. (2)
KBL MERGER CORP. IV (10)
Kiromic Biopharma, Inc. (28)
KIWA BIO-TECH PRODUCTS GROUP CORP (7)
Kodiak Sciences Inc. (4)
Kura Oncology, Inc. (4)
LA JOLLA PHARMACEUTICAL CO (1)
Leisure Acquisition Corp. (19)
LEXICON PHARMACEUTICALS, INC. (1)
LifeSci Acquisition Corp. (1)
Ligand Pharmaceuticals Incorporated (6)
Locust Walk Acquisition Corp. (2)
LONGEVERON LLC (1)
MADRIGAL PHARMACEUTICALS, INC. (4)
MANHATTAN SCIENTIFICS INC (5)
MANNKIND CORP (16)
MARIZYME INC (31)
Marker Therapeutics, Inc. (4)
MATEON THERAPEUTICS INC (22)
Medovex Corp. (19)
MiMedx Group, Inc. (7)
Minerva Neurosciences, Inc. (14)
MiNK Therapeutics, Inc. (5)
MIRAGEN THERAPEUTICS, INC. (2)
Molecular Templates, Inc. (1)
NANOVIRICIDES, INC. (2)
NantKwest, Inc. (21)
NAVIDEA BIOPHARMACEUTICALS, INC. (9)
NEWLINK GENETICS CORP (5)
NexImmune, Inc. (1)
NORTHWEST BIOTHERAPEUTICS INC (3)
NOVAVAX INC (10)
NTN BUZZTIME INC (9)
Nuo Therapeutics, Inc. (19)
Ohr Pharmaceutical Inc (2)
OncBioMune Pharmaceuticals, Inc (36)
OncoCyte Corp (1)
ONCOSEC MEDICAL Inc (1)
OPGEN INC (17)
Opko Health, Inc. (7)
ORAGENICS INC (23)
Organicell Regenerative Medicine, Inc. (3)
Organogenesis Holdings Inc. (4)
Orgenesis Inc. (14)
Outlook Therapeutics, Inc. (11)
PDL BIOPHARMA, INC. (3)
Petra Acquisition Inc. (5)
PharmaCyte Biotech, Inc. (1)
PIERIS PHARMACEUTICALS, INC. (2)
POLARITYTE, INC. (1)
PRECISION BIOSCIENCES INC (2)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
PREMIER BIOMEDICAL INC (25)
PROGENITY, INC. (5)
Propanc Biopharma, Inc. (111)
Protagenic Therapeutics, Inc. (20)
Protalix BioTherapeutics, Inc. (7)
PROTEOSTASIS THERAPEUTICS, INC. (1)
ProtoKinetix, Inc. (2)
PTC THERAPEUTICS, INC. (1)
PUMA BIOTECHNOLOGY, INC. (7)
Q BioMed Inc. (3)
Qrons Inc. (5)
Radius Health, Inc. (5)
Rasna Therapeutics Inc. (2)
Regeneron Pharmaceuticals (2)
REGENERX BIOPHARMACEUTICALS INC (14)
Regulus Therapeutics Inc. (1)
RenovaCare, Inc. (5)
RenovoRx, Inc. (3)
Retrophin, Inc. (4)
REXAHN PHARMACEUTICALS, INC. (4)
Rezolute, Inc. (3)
Rich Pharmaceuticals, Inc. (46)
RITTER PHARMACEUTICALS INC (7)
Sarepta Therapeutics, Inc. (1)
SELLAS Life Sciences Group, Inc. (6)
Shuttle Pharmaceuticals Holdings, Inc. (23)
Social Capital Suvretta Holdings Corp. III (2)
SOLENO THERAPEUTICS INC (7)
Sorrento Therapeutics, Inc. (7)
Spectrum Pharmaceuticals, Inc. (1)
SPHERIX INC (3)
Spinning Eagle Acquisition Corp. (1)
Stellar Biotechnologies, Inc. (1)
Summit Therapeutics Inc. (7)
Sun BioPharma, Inc. (10)
SUNESIS PHARMACEUTICALS INC (2)
Sunshine Biopharma, Inc (1)
Syndax Pharmaceuticals Inc (2)
Synthetic Biologics, Inc. (1)
TENAX THERAPEUTICS, INC. (4)
TG THERAPEUTICS, INC. (3)
Tonix Pharmaceuticals Holding Corp. (1)
Trovagene, Inc. (1)
U.S. Stem Cell, Inc. (8)
United Therapeutics Corp (1)
USA EQUITIES CORP. (6)
VACCINEX, INC. (1)
Vertex Pharmaceuticals Inc (2)
Vicapsys Life Sciences, Inc. (1)
Viking Therapeutics, Inc. (1)
VistaGen Therapeutics, Inc. (12)
VITRO DIAGNOSTICS INC (15)
WINDTREE THERAPEUTICS INC (10)
Xenetic Biosciences, Inc. (5)
XOMA Corp (3)
YIELD10 BIOSCIENCE, INC. (4)

Recent Contracts

Form of Unsecured Bridge Note (GX Acquisition Corp., Filed With SEC on December 2, 2024)
Senior Convertible Promissory Tranche B Note issued to Nant Capital, LLC, dated November 15, 2024 (Sun BioPharma, Inc., Filed With SEC on November 18, 2024)
Form of First Amendment to the Amended and Restated Senior Secured Note Purchase Agreement, dated September 30, 2024, by and between the Company and Purchaser parties thereto (HCW Biologics Inc., Filed With SEC on November 14, 2024)
Subordinated Promissory Note, dated as of August 19, 2024 (Sun BioPharma, Inc., Filed With SEC on November 14, 2024)
Amendment No. 1 to the Secured Promissory Note between the Company and Nuseed Nutritional US Inc. dated November 7, 2024 (YIELD10 BIOSCIENCE, INC., Filed With SEC on November 12, 2024)
Secured Promissory Note between the Company and Nuseed Nutritional US Inc. dated September 5, 2024 (YIELD10 BIOSCIENCE, INC., Filed With SEC on November 12, 2024)
Convertible Promissory Note dated November 7, 2024 payable to Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on November 8, 2024)
Fifth Amended and Restated Note Purchase Agreement dated as of November 7, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on November 8, 2024)
Promissory Note, dated as of November 4, 2024, by and between Orgenesis Maryland LLC, the Company and Jacob Safier (Orgenesis Inc., Filed With SEC on November 5, 2024)
Senior Convertible Promissory Tranche A Note issued to Nant Capital, LLC, dated October 22, 2024 (Sun BioPharma, Inc., Filed With SEC on October 28, 2024)
Note Purchase Agreement, dated October 22, 2024, between Nant Capital, LLC, as Investor, and Panbela Therapeutics, Inc., as Company (Sun BioPharma, Inc., Filed With SEC on October 28, 2024)
Clinical Trial Funding Agreement, by and among Double Point Ventures LLC and Lumos Pharma, Inc., dated October 22, 2024 (including the form of Note with respect thereto) (NEWLINK GENETICS CORP, Filed With SEC on October 23, 2024)
Form of Senior Secured Convertible Notes (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on October 17, 2024)
Amendment to Convertible Promissory Notes dated as of October 8, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on October 8, 2024)
Convertible Promissory Note dated October 8, 2024 payable to Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on October 8, 2024)
Fourth Amended and Restated Note Purchase Agreement dated as of October 8, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on October 8, 2024)
Amendment to Form of Senior Secured Convertible Promissory Note due March 8, 2027 (DYADIC INTERNATIONAL INC, Filed With SEC on October 8, 2024)
Convertible Promissory Note dated September 20, 2024 (Propanc Biopharma, Inc., Filed With SEC on September 27, 2024)
Form of 12.0% senior convertible note issued under the note purchase agreement, dated as of September 24, 2024, between Eterna Therapeutics Inc. and the purchaser parties thereto (NTN BUZZTIME INC, Filed With SEC on September 25, 2024)
Note purchase agreement, dated as of September 24, 2024, between Eterna Therapeutics Inc. and the purchaser parties thereto (NTN BUZZTIME INC, Filed With SEC on September 25, 2024)
Form of Senior Note (September 2024) (ADiTx Therapeutics, Inc., Filed With SEC on September 23, 2024)
Form of Note issued on September 15, 2024 (International Stem Cell CORP, Filed With SEC on September 17, 2024)
Form of Promissory Note, dated September 4, 2024, between Shuttle Pharmaceuticals and Anatoly Dritschilo (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on September 10, 2024)
Convertible Promissory Note dated September 9, 2024 payable to Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on September 9, 2024)
Third Amended and Restated Note Purchase Agreement dated as of September 9, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (CTD HOLDINGS INC, Filed With SEC on September 9, 2024)
Form of Waiver to Senior Note (ADiTx Therapeutics, Inc., Filed With SEC on August 28, 2024)
Amended and Restated Promissory Note, dated as of August 23, 2024, by and between Orgenesis Maryland LLC, Jacob Safier and Orgenesis Inc (Orgenesis Inc., Filed With SEC on August 26, 2024)
Convertible Promissory Note dated August 21, 2024 payable to Rafael (CTD HOLDINGS INC, Filed With SEC on August 22, 2024)
Second Amended and Restated Note Purchase Agreement dated as of August 21, 2024 by and among the Company and Rafael (CTD HOLDINGS INC, Filed With SEC on August 22, 2024)
Convertible Promissory Note dated August 2, 2024 (Propanc Biopharma, Inc., Filed With SEC on August 15, 2024)
Form of Senior Secured Promissory Note by and between the Company and the Holder party thereof (HCW Biologics Inc., Filed With SEC on August 14, 2024)
Form of Amended and Restated Senior Secured Note Purchase Agreement, dated July 2, 2024, by and between the Company and the Purchaser party thereto (HCW Biologics Inc., Filed With SEC on August 14, 2024)
Subordinated Promissory Note, dated as of August 8, 2024 (Sun BioPharma, Inc., Filed With SEC on August 13, 2024)
Form of Note Purchase Agreement, dated August 12, 2024, between the Company and the purchasers named therein (PROGENITY, INC., Filed With SEC on August 12, 2024)
Form of 2024 Convertible Note Purchase Agreement (PIERIS PHARMACEUTICALS, INC., Filed With SEC on August 9, 2024)
Form of Convertible Promissory Note (PIERIS PHARMACEUTICALS, INC., Filed With SEC on August 9, 2024)
Form of Note dated July 17, 2024 (Opko Health, Inc., Filed With SEC on August 7, 2024)
Note Purchase Agreement dated July 17, 2024 by and among the Company, certain purchasers party thereto, OPKO Biologics Limited, Eirgen Pharma Ltd. and HCR Injection SPV, LLC as... (Opko Health, Inc., Filed With SEC on August 7, 2024)
25% Senior Secured Convertible Promissory Note, dated August 1, 2024 (Kiromic Biopharma, Inc., Filed With SEC on August 5, 2024)
Note Cancellation and Amendment to Asset and Equity Interests Purchase Agreement, effective July 30, 2024 (HEAT BIOLOGICS, INC., Filed With SEC on July 31, 2024)